IRIS
PASINI, AUGUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.266
EU - Europa 2.381
AS - Asia 1.068
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
AF - Africa 2
Totale 36.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.236
SG - Singapore 542
UA - Ucraina 469
DE - Germania 432
CN - Cina 329
IE - Irlanda 277
IT - Italia 254
SE - Svezia 227
RU - Federazione Russa 157
GB - Regno Unito 155
FR - Francia 129
FI - Finlandia 104
KR - Corea 93
PL - Polonia 79
TW - Taiwan 32
BE - Belgio 26
CZ - Repubblica Ceca 24
CA - Canada 23
BR - Brasile 21
IN - India 19
NL - Olanda 15
JP - Giappone 14
EU - Europa 13
IL - Israele 11
AU - Australia 9
CL - Cile 9
CH - Svizzera 8
MX - Messico 7
IR - Iran 6
AT - Austria 5
ES - Italia 5
AL - Albania 4
HK - Hong Kong 3
KZ - Kazakistan 3
MY - Malesia 3
TR - Turchia 3
AR - Argentina 2
GR - Grecia 2
ID - Indonesia 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 36.776
Salva come PNG Salva come JPEG
Città #
Woodbridge 10.607
Wilmington 8.700
Houston 7.890
Fairfield 944
Ann Arbor 898
Chandler 577
Singapore 478
Ashburn 448
Jacksonville 429
Seattle 370
Cambridge 326
Dublin 271
Medford 207
Dearborn 177
Beijing 143
New York 133
Santa Clara 105
Lawrence 101
Kraków 75
Mülheim 64
Rome 56
Menlo Park 50
San Diego 49
Redwood City 46
Boardman 41
Zhengzhou 37
Falls Church 35
Milan 34
Taipei 32
Norwalk 31
Moscow 29
Palo Alto 28
Mountain View 25
Brno 24
Brussels 23
San Mateo 22
Nanjing 21
University Park 17
London 16
Kunming 15
Toronto 13
Hefei 12
Munich 12
Nanchang 12
Verona 12
Washington 11
Guangzhou 10
Los Angeles 10
Detroit 8
Helsinki 8
Nürnberg 8
Catania 7
Hyderabad 7
Indiana 7
Jinan 7
Saint Petersburg 7
Shanghai 7
São Paulo 7
Auburn Hills 6
Melbourne 6
Bologna 5
Nuremberg 5
Busto Arsizio 4
Castellabate 4
Chengdu 4
Chicago 4
Groningen 4
Hangzhou 4
Kilburn 4
Padova 4
Phoenix 4
Pune 4
Redmond 4
Tokyo 4
Almaty 3
Amsterdam 3
Brasília 3
Fort Lauderdale 3
Fuzhou 3
Hebei 3
Hounslow 3
Issy-les-Moulineaux 3
Kuala Lumpur 3
Leuven 3
Lyon 3
Monteroni 3
Seoul 3
Acerra 2
Bethesda 2
Blackwood 2
Bloomsbury 2
Brewster 2
Capua 2
Carrara 2
Changsha 2
Chiswick 2
Frankfurt am Main 2
Fremont 2
Gangnam-gu 2
Goiânia 2
Totale 33.874
Salva come PNG Salva come JPEG
Nome #
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment 509
Association study of a promoter polymorphism of UFD1L gene with schizophrenia 461
Alexithymia as related to sex, age, and educational level: Results of the Toronto Alexithymia Scale in 417 normal subjects 450
Association between schizohprenia and UFD1L. A developmental gene mapped to chromosome 22 447
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study 446
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients 443
Human endogenous retroviruses and ADHD 435
Neuroleptic treatments and overflow movements in schizophrenia: are they independent? 434
Patients with deficit, nondeficit, and negative symptom schizophrenia: Do they differ during episodes of acute psychotic decompensation? 433
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients. 432
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case-control study 430
Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy 430
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 429
Assessing attentional systems in children with Attention Deficit Hyperactivity Disorder 429
Detecting anxiety symptoms in children and youths with neurofibromatosis type I 428
Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia 421
Fluoxetine alone in the treatment of first episode anxious-depression: An open clinical trial 420
Impairment in flexible regulation of speed and accuracy in children with ADHD 420
Residential facilities for older people in Italy: a five-region survey 420
Fluoxetine decreases concentrations of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression 417
Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings 416
Effects of antidepressant treatment on neuroactive steroids in major depression 411
Neurosteroids as neuromodulators in the treatment of anxiety disorders 411
5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo 409
Adhd and human endogenous retroviruses 408
Typical and atypical antipsychotic use in aggressive children and adolescents: A systematic review [Uso degli antipsicotici tipici e atipici nel trattamento dell'aggressività nell'infanzia e nell'adolescenza: Revisione sistematica della letteratura] 407
Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. 403
ALEXITHYMIA AS RELATED TO SEX, AGE, AND EDUCATIONAL-LEVEL - RESULTS OF THE TORONTO ALEXITHYMIA SCALE IN 417 NORMAL SUBJECTS 402
Neuroactive steroids in responders and nonresponders to sleep deprivation 400
Overflow movements and white matter abnormalities in ADHD 400
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 400
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 395
Controlling attention to gaze and arrows in attention deficit hyperactivity disorder 395
Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy 394
Change blindness in children with ADHD: a selective impairment in visual search? 392
Asynchronicity of Organic and Psychiatric Symptoms in a Case of Sertraline Intoxication 391
Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention 390
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia 389
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 388
Alexithymic features in stroke: Effects of laterality and gender 387
Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder preliminary results 384
Psychiatric symptoms in male cannabis users not using other illicit drugs 384
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 384
Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression 383
Pathophysiology of NSS in ADHD 383
Overflow movements and white matter abnormalities in ADHD 381
Impaired reflexive orienting to social cues in attention deficit hyperactivity disorder 381
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery 380
Inhibition of return in response to eye gaze and peripheral cues in young people with Asperger's syndrome 380
Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder 379
Increased neurosteroids synthesis after brain and spinal cord injury in rats 378
Reduced prefrontal cognitive activation associated with aggression in schizophrenia 377
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 377
Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities 376
Ethological predictors of amitriptyline response in depressed outpatients 374
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers 370
Attention and executive functions profile in drug naive ADHD subtypes 369
Anticonvulsant effect of intranigral fluoxetine 369
Nonverbal behavior and alexithymic traits in normal subjects. Individual differences in encoding emotions 367
Marked decrease of plasma neuroactive steroids during alcohol withdrawa 363
The complex roles of neurosteroids in depression and anxiety disorders. 362
Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3 alpha, 5 alpha tetrahydrodeoxycorticosterone (3 alpha, 5 alpha-THDOC) in healthy volunteers 358
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients 357
[Executive function deficits in ADHD and Asperger syndrome] 355
Altered anandamide degradation in attention-deficit/hyperactivity disorder 354
The neurobiology of attention deficit/hyperactivity disorder. 354
Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers [1] 353
Fluoxetine and seizures 350
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 347
Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms 347
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3 alpha-hydroxysteroid dehydrogenase activity 346
Is it confirmed the presence of neurological soft signs in children with Neurofibromatosis type 1? 345
A Small Supernumerary Marker Derived from the Pericentromeric Region of Chromosome 5: Case Report and Delineation of Partial Trisomy 5p Phenotype 344
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders 343
Neurological soft signs, but not theory of mind and emotion recognition deficit distinguished children with ADHD from healthy control 343
Visual search and emotion: how children with autism spectrum disorders scan emotional scenes 340
Motor examination in children with Attention-deficit/hyperactivity Disorder and Asperger Syndrome 338
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. 337
Comorbidity of ADHD and High-functioning Autism: A Pilot Study on the Utility of the Overflow Movements Measure 330
Pathophysiology of NSS in ADHD 329
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin 328
Explicit incestuous motifs and emotional crises in psychosomatic patients 326
Ethological assessment of the DSM-III subtyping of unipolar depression 326
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients 323
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome 320
Neurosteroids in developmental disorders 315
Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations 314
LE ALLUCINAZIONI 313
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD 313
Neuroactive steroids as modulators of depression and anxiety 311
[Executive function deficits in ADHD and Asperger syndrome] 303
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin 302
Non-verbal behaviour deficits in schizophrenia: an ethological study of drug-free patients 290
Influence of sleep deprivation major depression on neuroactive steroids in major depression 288
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome. 272
Il Delirio 265
I retrovirus endogeni nella sindrome da deficit di attenzione e iperattività (ADHD). 254
Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders 221
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 118
Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: A pilot study 117
Totale 36.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.459 0 0 0 0 0 1.042 849 801 824 745 590 608
2020/20215.305 646 602 621 709 487 574 658 466 120 128 207 87
2021/20221.089 43 123 97 65 25 126 42 54 77 96 64 277
2022/20231.478 129 92 39 217 145 344 120 102 132 2 125 31
2023/2024525 62 27 43 13 45 180 51 7 4 10 9 74
2024/20251.041 104 470 264 125 50 28 0 0 0 0 0 0
Totale 36.916